Viviana Galimberti

Author PubWeight™ 90.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003 11.93
2 Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 2013 4.21
3 Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 2004 3.87
4 Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 2010 3.61
5 NUMB controls p53 tumour suppressor activity. Nature 2008 2.91
6 Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment. Clin Cancer Res 2004 2.46
7 Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006 2.36
8 Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. J Clin Oncol 2012 2.22
9 Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. J Clin Oncol 2009 1.85
10 Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 2005 1.73
11 Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003 1.63
12 Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat 2010 1.59
13 Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer 2004 1.48
14 Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 2005 1.47
15 Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg 2005 1.47
16 Axillary radiotherapy instead of axillary dissection: a randomized trial. Italian Oncological Senology Group. Ann Surg Oncol 2002 1.46
17 Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005 1.45
18 Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin. Eur J Nucl Med Mol Imaging 2009 1.45
19 Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer 2009 1.28
20 Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy. Breast Cancer Res Treat 2008 1.24
21 Male breast cancer: a special therapeutic problem. Anything new? (Review). Int J Oncol 2004 1.18
22 Invasive lobular breast cancer: subtypes and outcome. Breast Cancer Res Treat 2012 1.11
23 Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution. Cancer 2004 1.11
24 Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution. Cancer 2008 1.06
25 Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome. Clin Breast Cancer 2012 1.05
26 IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation. Breast 2006 1.04
27 When sentinel lymph node is intramammary. Ann Surg Oncol 2007 1.03
28 Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research. Breast J 2009 1.02
29 Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Ann Surg Oncol 2007 1.00
30 Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial. Cancer Prev Res (Phila) 2011 0.99
31 The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat 2005 0.96
32 Breast-conserving surgery in 201 very young patients (<35 years). Breast 2009 0.95
33 Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. Int J Radiat Oncol Biol Phys 2008 0.95
34 Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer? Ann Surg Oncol 2009 0.94
35 Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancer. Radiother Oncol 2005 0.93
36 The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat 2005 0.93
37 Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch Surg 2002 0.92
38 Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol 2005 0.91
39 Sentinel lymph node biopsy performed with local anesthesia in patients with early-stage breast carcinoma. Arch Surg 2002 0.90
40 Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging 2010 0.89
41 Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat 2008 0.89
42 Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases. Oncologist 2010 0.88
43 The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy. Breast Cancer Res Treat 2010 0.87
44 Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users. Ann Surg Oncol 2002 0.87
45 Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer. Clin Cancer Res 2007 0.86
46 BC-box protein domain-related mechanism for VHL protein degradation. Proc Natl Acad Sci U S A 2013 0.86
47 Conservative treatment of breast cancer: its evolution. Breast Cancer Res Treat 2005 0.86
48 Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat 2014 0.85
49 Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat 2008 0.85
50 Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation. Breast Cancer Res Treat 2011 0.85
51 Immediate breast reconstruction after mastectomy. Breast 2011 0.85
52 Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome. Breast 2010 0.84
53 E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev 2014 0.84
54 Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat 2008 0.83
55 Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique. Ann Surg 2015 0.83
56 Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer. Breast Cancer Res Treat 2013 0.83
57 International Breast Cancer Study Group Trial of sentinel node biopsy. J Clin Oncol 2006 0.83
58 Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates. Ann Surg Oncol 2012 0.83
59 Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer--authors' reply. Lancet Oncol 2013 0.81
60 Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapy. Eur J Nucl Med Mol Imaging 2010 0.80
61 Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome. J Surg Oncol 2006 0.80
62 Incidence, predictive factors, and prognosis for winged scapula in breast cancer patients after axillary dissection. Support Care Cancer 2014 0.78
63 Immediate breast reconstruction with expander in pregnant breast cancer patients. Breast 2013 0.78
64 The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of life. Breast Cancer Res Treat 2005 0.78
65 Local therapy for breast cancer in malignant lymphoma survivors. Breast 2011 0.78
66 Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer 2006 0.77
67 Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA. Breast Cancer Res Treat 2006 0.77
68 Clinical utility of 99mTc-Sestamibi scintimammography in the management of equivocal breast lesions. Cancer Biother Radiopharm 2004 0.76
69 Immediate breast reconstruction with prostheses after conservative treatment plus intraoperative radiotherapy. long term esthetic and oncological outcomes. Breast 2012 0.76
70 Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution. Ann Surg Oncol 2011 0.75
71 Second malignancies following breast cancer treatment: a case-control study based on the Peridose methodology. Allegro project (task 5.4). Tumori 2012 0.75
72 No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN). Eur J Cancer 2010 0.75
73 Feasibility of lymphoscintigraphy for sentinel node identification after neo-adjuvant therapy. Ann Ital Chir 2017 0.75
74 Erratum to: Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat 2015 0.75
75 BRCA1/2 germline missense mutations: a systematic review. Eur J Cancer Prev 2017 0.75
76 Robotic Nipple-sparing Mastectomy and Immediate Breast Reconstruction With Implant: First Report of Surgical Technique. Ann Surg 2017 0.75
77 Report on a case of breast sarcoma metastatic to the axillary lymph nodes. Tumori 2006 0.75